ELEVATE – Evaluating Temozolomide and Nivolumab in Patients with Advanced Unresectable Previously Treated Oesophagogastric Adenocarcinoma with MGMT Methylation: Study Protocol for a Single Arm Phase II Trial
BMC Cancer(2022)
Key words
Oesophagogastric adenocarcinoma,Immunotherapy,MGMT methylated,Phase II
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined